The salary is not very high in the same industry, but the production management process of listed companies is very standardized, and we can learn a lot from them. Generally speaking, this company is very suitable for the first employment and the first stop of career planning.
WuXi PharmaTech's full name is WuXi PharmaTech New Drug Development Co., Ltd., which was established in Wuxi, Jiangsu Province in 2000 and has an operation center in Shanghai. As a platform of all biochemical technologies and capabilities, Wuxi PharmaTech provides global customers with all-round integrated services and solutions covering drug discovery, pharmacology and pharmacodynamics in various disease fields, helping and accelerating the process of drug research and development. Innovate the excellent ability and technical platform of research and development and production of chemical drugs, and strive to provide efficient, flexible and high-quality one-stop solutions from raw materials to preparations for global partners.
Wuxi pharmatech's vision: to become the highest, widest and deepest production capacity and technology platform in the global medical and health industry, so that there are no difficult drugs and diseases.
WuXi PharmaTech's mission: to create and improve an open platform of capabilities and technologies, and provide personalized treatment and health management solutions, so that the R&D dream of anyone and any company can be realized and patients can benefit from more and better pharmaceutical products.
Wuxi pharmatech's core values: honesty and dedication, * * * suffering * * *; Do the right thing and do it well.
Wuxi pharmatech's code of conduct: customer first, honesty, Excellence, efficient execution, cross-border cooperation and innovation.
Since its establishment, the company has won many honors. 2008-2065 438+03 was selected as "Top Ten Service Outsourcing Enterprises in China" for six consecutive years. From 2005 to 2009, it won the "Top 50 High-tech Growth of Deloitte China" for five consecutive years; From 2004 to 2009, it won the title of "Deloitte Asia-Pacific Top 500 High-tech Growth" for six consecutive years.